<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-11T12:06:45+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>原创新药FWD1509将揭开EGFR 20外显子插入突变神秘面纱</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/4I8bM90G5P-81b25Z0PPXA</id>
    <link href="https://mp.weixin.qq.com/s/4I8bM90G5P-81b25Z0PPXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>微芯生物抗肿瘤原创新药西奥罗尼纳入CDE“突破性治疗”</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/ANnwQpj2_x1pXCRucgpcOQ</id>
    <link href="https://mp.weixin.qq.com/s/ANnwQpj2_x1pXCRucgpcOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药：共计49个产品通过一致性评价</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/3aCLuFDFsYN1VN9JeS5qdw</id>
    <link href="https://mp.weixin.qq.com/s/3aCLuFDFsYN1VN9JeS5qdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗全民免费接种！医保基金和财政共同负担</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/xmYoxOihmhWOdSQmmtiPzA</id>
    <link href="https://mp.weixin.qq.com/s/xmYoxOihmhWOdSQmmtiPzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谷氨酰胺酶抑制剂Telaglenastat肾癌试验失败，Calithera Biosciences预计裁员35%</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/OEPlST806KsOJfT0tCRhjw</id>
    <link href="https://mp.weixin.qq.com/s/OEPlST806KsOJfT0tCRhjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Scorpion超额完成1.62亿美元B轮融资，加速精准肿瘤2.0开发</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/f47BFQjJRNwEs0guPJy2Zg</id>
    <link href="https://mp.weixin.qq.com/s/f47BFQjJRNwEs0guPJy2Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Insilico Medicine宣布与新旭生技达成AI新药合作开发协议</title>
    <updated>2021-01-10T21:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/KhhzusdYNPV1wgbk2s3IGQ</id>
    <link href="https://mp.weixin.qq.com/s/KhhzusdYNPV1wgbk2s3IGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维昇药业宣布完成1.5亿美元B轮融资，加速大中华区创新内分泌疗法研发</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/GV7y2YXU50VYXy12i1oZnA</id>
    <link href="https://mp.weixin.qq.com/s/GV7y2YXU50VYXy12i1oZnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>展望2021：中国生物医药企业在不确定大环境中切实抓住创新机遇</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/dX5MjAyUrKFTXiwcS-OfrQ</id>
    <link href="https://mp.weixin.qq.com/s/dX5MjAyUrKFTXiwcS-OfrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和誉医药完成1.23亿美元D轮融资</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/tt2yAULJUsln5ZmFuPZG7A</id>
    <link href="https://mp.weixin.qq.com/s/tt2yAULJUsln5ZmFuPZG7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>血友病在研新药汇总</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/2xuhEOBnboREzO9dRtujAg</id>
    <link href="https://mp.weixin.qq.com/s/2xuhEOBnboREzO9dRtujAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘李药业门冬胰岛素获得印度尼西亚原料药注册批件</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/xZbK4V_BSj1yGwxWPGNJbw</id>
    <link href="https://mp.weixin.qq.com/s/xZbK4V_BSj1yGwxWPGNJbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE《化学药品注射剂灭菌和无菌工艺研究及验证指导原则（试行）》</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/NuSRzaVmFG_OQR_w7fgNtQ</id>
    <link href="https://mp.weixin.qq.com/s/NuSRzaVmFG_OQR_w7fgNtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EZH2抑制剂： 基于表观遗传的肿瘤免疫治疗药物，恒瑞布局</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/5L7sPahOAs2MHpB5f9zGUA</id>
    <link href="https://mp.weixin.qq.com/s/5L7sPahOAs2MHpB5f9zGUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COVID-19对2020年生物制药并购的影响</title>
    <updated>2021-01-09T22:21:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/iOq1VFpmAIDwkibHCj6few</id>
    <link href="https://mp.weixin.qq.com/s/iOq1VFpmAIDwkibHCj6few" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【产业观察】以为小适应症，结果TRK新药大热门</title>
    <updated>2021-01-08T16:50:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/xL1yMDwyPgAuytLn1q9wjg</id>
    <link href="https://mp.weixin.qq.com/s/xL1yMDwyPgAuytLn1q9wjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！全球CAR-M疗法公司完成4700万美元B轮融资，丽珠医药参投</title>
    <updated>2021-01-08T16:50:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/nYHdrt_PiHJtpr2zZYR08A</id>
    <link href="https://mp.weixin.qq.com/s/nYHdrt_PiHJtpr2zZYR08A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>易明医药——扎根西藏，雅鲁藏布江畔的新型药企</title>
    <updated>2021-01-08T16:50:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/qc0DFyEungk7a_pXufWfoQ</id>
    <link href="https://mp.weixin.qq.com/s/qc0DFyEungk7a_pXufWfoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球癌症形势严峻，靶向和免疫疗法仍是肿瘤研发热点</title>
    <updated>2021-01-08T16:50:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/FOVrJ30sKAos4EuibVxvQw</id>
    <link href="https://mp.weixin.qq.com/s/FOVrJ30sKAos4EuibVxvQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科越医药完成5350万美元B+轮1期融资，开发补体靶向疗法</title>
    <updated>2021-01-08T16:50:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/ddNwys8cLhGlrD6akoVsPg</id>
    <link href="https://mp.weixin.qq.com/s/ddNwys8cLhGlrD6akoVsPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>